GV VISIONARY HOLDINGS INC.

Visionary Holdings Inc. Regains Compliance with Nasdaq Periodic Filing Requirement

Visionary Holdings Inc. Regains Compliance with Nasdaq Periodic Filing Requirement

TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) in connection with the filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025.

As previously disclosed, on August 5, 2025, the Company was notified by Nasdaq that it was not in compliance with the periodic filing requirement under Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025.

Based on the Company’s filing of its Form 20-F on January 28, 2026, Nasdaq has determined that the Company has now regained compliance with the applicable listing requirements. On January 29, 2026, Nasdaq advised the Company that this matter is now closed.

The Company remains committed to maintaining full compliance with all applicable Nasdaq listing standards and U.S. securities laws, and to upholding a high level of transparency and disclosure for the benefit of its shareholders.

About Visionary Holdings Inc.

Visionary Holdings Inc. (Nasdaq: GV) is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions. Headquartered in Toronto, Canada, the Company operates through its subsidiaries across North America and Asia, driving technological advancement, cross-border innovation, and global health transformation.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. The Company undertakes no obligation to update any forward-looking statements, except as required by law.

Visionary Holdings Inc.

For further information:

Investor Relations

Visionary Holdings Inc.

Email:



EN
02/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on VISIONARY HOLDINGS INC.

 PRESS RELEASE

Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAM...

Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales Company Continues Expansion into North America and Europe as Part of Global Medical Aesthetics Strategy HONG KONG, March 05, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”), a technology-driven multinational enterprise focused on healthcare services, medical aesthetics, and advanced biotechnology applications, today provided its 2026–2027 business outlook and strategic growth priorities as the Company cont...

 PRESS RELEASE

Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Mi...

Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses HONG KONG, March 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational and biotechnology and healthcare-focused company, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), today announced the signing of a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex---Presid...

 PRESS RELEASE

Visionary Holdings Announces Continued Progress of Approximately US$9 ...

Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract Expects Significant Milestone Advancement by the End of March 2026 HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), continued execution progress under its previously signed commercial sales agreement with a total contract value of approximately US$9 million. The agreement, signed in September...

 PRESS RELEASE

Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidi...

Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China HONG KONG, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”) (Nasdaq: GV), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has established three new regional wholly owned subsidiaries in Qingdao, Wuxi and Wuhu, China. These subsidiaries are primarily dedicated to localized market expansion, institutional partnerships, and fron...

 PRESS RELEASE

Visionary Holdings Inc. Secures $450,000 in Debt Financing

Visionary Holdings Inc. Secures $450,000 in Debt Financing TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”) announced today that in December 2025 it entered into a securities purchase agreement with an existing institutional investor (the “Investor”). In connection with the transaction, the Company issued to the Investor a senior secured convertible promissory note in the principal amount of $500,000 (the “December 2025 Note”) in exchange for gross proceeds of $450,000. As previously disclosed, on January 31, 2025, the Company...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch